Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;21(5):275-290.
doi: 10.1038/s41584-025-01240-x. Epub 2025 Apr 7.

IgG4-related disease and other fibro-inflammatory conditions

Affiliations
Review

IgG4-related disease and other fibro-inflammatory conditions

Francesco Peyronel et al. Nat Rev Rheumatol. 2025 May.

Abstract

IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder usually characterized by multi-organ involvement. Its pathogenesis is complex and involves genetic and environmental factors, while immune responses usually mediate organ damage and promote fibrosis, which is a key feature of the disease. IgG4 responses, however, are not exclusive to IgG4-RD and can be encountered in other diseases with phenotypes that partially overlap that of IgG4-RD. Although IgG4-RD has clinical and histological hallmarks, the lack of validated diagnostic criteria often makes the diagnosis challenging, requiring a multi-dimensional approach that integrates clinical, radiological and serological data. The present Review covers recent advances in the understanding of disease drivers and its clinical phenotypes, mainly focusing on the differential diagnosis with potential IgG4-RD mimickers, namely histiocytoses, lymphoproliferative disorders, systemic vasculitides and other immune-mediated conditions. The Review also provides a schematic approach to IgG4-RD treatment, including a brief overview of glucocorticoid-sparing agents and emerging therapies, from B cell-depleting monoclonal antibodies to cytokine-targeting drugs, the majority of which are currently under investigation in randomized clinical trials.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Hamano, H. et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732–738 (2001). - PubMed - DOI
    1. Hamano, H. et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359, 1403–1404 (2002). - PubMed - DOI
    1. Kamisawa, T. et al. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 38, 982–984 (2003). - PubMed - DOI
    1. Stone, J. H., Zen, Y. & Deshpande, V. IgG4-related disease. N. Engl. J. Med. 366, 539–551 (2012). - PubMed - DOI
    1. Maritati, F. et al. Clinical and prognostic significance of serum IgG4 in chronic periaortitis. An analysis of 113 patients. Front. Immunol. 10, 693 (2019). - PubMed - PMC - DOI

MeSH terms

Substances

LinkOut - more resources